SCHEMBL3898531

SCHEMBL3898531

Fc1ccc(Oc2ccccc2Br)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
L3MBTL1 Q9Y468 4/20 0.49
LMNA P02545 1/20 0.49
MAPK1 P28482 2/20 0.45
HTT P42858 2/20 0.45
SLC6A2 P23975 4/20 0.45
SLC6A4 P31645 4/20 0.45
SLC6A3 Q01959 4/20 0.45
HTR1A P08908 3/20 0.45
NR3C1 P04150 1/20 0.44
SOS1 Q07889 1/20 0.42
TDP1 Q9NUW8 2/20 0.41
MAPT P10636 1/20 0.41
MAP2K1 Q02750 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
PARP10 Q53GL7 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30039490 1.00 ALDH1A1 (0.49) ALDH1A1L3MBTL1LMNAMAPK1HTT
SCHEMBL3040454 0.98 ALDH1A1 (0.47) ALDH1A1L3MBTL1LMNAMAPK1HTT
SCHEMBL74839 0.91 ALDH1A1 (0.52) ALDH1A1L3MBTL1LMNAMAPK1HTT
SCHEMBL3843172 0.89 ALDH1A1 (0.50) ALDH1A1L3MBTL1LMNAMAPK1HTT
SCHEMBL8954758 0.84 LTA4H (0.55) ALDH1A1L3MBTL1LMNAMAPK1HTT
SCHEMBL3845666 0.84 SLC6A4 (0.53) ALDH1A1L3MBTL1LMNAMAPK1HTT
SCHEMBL130304 0.84 LTA4H (0.52) ALDH1A1L3MBTL1LMNAMAPK1HTT
SCHEMBL6290676 0.84 ALDH1A1 (0.61) ALDH1A1L3MBTL1LMNAMAPK1HTT
SCHEMBL4859489 0.82 LTA4H (0.50) ALDH1A1L3MBTL1LMNAMAPK1HTT
SCHEMBL6293775 0.81 ALDH1A1 (0.58) ALDH1A1L3MBTL1LMNAMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115521342-A Organometallic compound, light-emitting device including the same, and electronic device 三星显示有限公司 2022-12-27 CN disclosed
US-7498344-B2 Arylpiperidinol and arylpiperidine derivatives and pharmaceuticals containing the same ASUBIO PHARMA CO., LTD. (JP) 2009-03-03 US disclosed
EP-1635828-B1 4-(2-PHENYLOXYPHENYL)-PIPERIDINE OR -1,2,3,6-TETRAHYDROPYRIDINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS LUNDBECK & CO AS H (DK) 2008-04-23 EP disclosed
CN-101072561-A Diaminoalkane aspartic protease inhibitors VITAE PHARMACEUTICALS INC (US) 2007-11-14 CN disclosed
US-20060293360-A1 4-(2-Phenyloxyphenyl)-piperidine or-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors H. LUNDBECK A/S (DK) 2006-12-28 US disclosed
CN-1767829-A 4- (2-phenoxyphenyl) -piperidine or-1, 2,3, 6-tetrahydropyridine derivatives as 5-hydroxytryptamine reuptake inhibitors LUNDBECK & CO AS H (DK) 2006-05-03 CN disclosed
EP-0867183-B1 ARYLPIPERIDINOL AND ARYLPIPERIDINE DERIVATIVES AND DRUGS CONTAINING THE SAME DAIICHI SUNTORY PHARMA CO LTD (JP) 2004-10-06 EP disclosed
US-20040186138-A1 Arylpiperidinol and arylpiperidine derivatives and pharmaceuticals containing the same DAIICHI SUNTORY PHARMA CO., LTD. 2004-09-23 US disclosed
US-6706734-B2 ANTIISCHEMIC AGENTS; ANTICONVULSANTS; HEADACHES DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2004-03-16 US disclosed
US-20030130312-A1 Arylpiperidinol and arylpiperidine derivatives and pharmaceuticals containing the same ASUBIO PHARMA CO., LTD. (JP) 2003-07-10 US disclosed
US-6455549-B1 ANTIEPILEPTIC, ANTIISCHEMIC, AND ANTIMIGRAINE AGENTS; CALCIUM OVELOAD SUPPRESSANTS SUNTORY LIMITED (JP) 2002-09-24 US disclosed
EP-0867183-A1 ARYLPIPERIDINOL AND ARYLPIPERIDINE DERIVATIVES AND DRUGS CONTAINING THE SAME SUNTORY LIMITED (JP) 1998-09-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130312-A1 Arylpiperidinol and arylpiperidine derivatives and pharmaceuticals containing the same KCNH1, KCNH2, NPY1R ALDH1A1 2244/4885L3MBTL1 4333/4885LMNA 837/4885
US-20060293360-A1 4-(2-Phenyloxyphenyl)-piperidine or-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors HTR1D, TPH1, HTR2C ALDH1A1 84/4885L3MBTL1 4442/4885LMNA 4523/4885
US-20040186138-A1 Arylpiperidinol and arylpiperidine derivatives and pharmaceuticals containing the same KCNH1, KCNH2, NPY1R ALDH1A1 2244/4885L3MBTL1 4333/4885LMNA 837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.